These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12869175)

  • 1. Induction of chronic cardiac insufficiency by arteriovenous fistula and doxorubicin administration.
    Tessier D; Lajos P; Braunberger E; Pouchelon JL; Carpentier A; Chachques JC; Chetboul V
    J Card Surg; 2003; 18(4):307-11. PubMed ID: 12869175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of heart failure: haemodynamic comparison of three different canine models.
    Djelmami-Hani M; Kazemi S; Hare J; Chekanov VS
    Lab Anim; 2007 Jan; 41(1):63-70. PubMed ID: 17234051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin-induced canine CHF: advantages and disadvantages.
    Astra LI; Hammond R; Tarakji K; Stephenson LW
    J Card Surg; 2003; 18(4):301-6. PubMed ID: 12869174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac safety profile of patients receiving high cumulative doses of pegylated-liposomal doxorubicin: use of left ventricular ejection fraction is of unproven value.
    Skubitz KM; Blaes AH; Konety SH; Francis GS
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):787-798. PubMed ID: 28856562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term and long-term models of doxorubicin-induced cardiomyopathy in rats: A comparison of functional and histopathological changes.
    O'Connell JL; Romano MM; Campos Pulici EC; Carvalho EE; de Souza FR; Tanaka DM; Maciel BC; Salgado HC; Fazan-Júnior R; Rossi MA; Simões MV
    Exp Toxicol Pathol; 2017 Apr; 69(4):213-219. PubMed ID: 28153388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A canine model of dilated cardiomyopathy induced by repetitive intracoronary doxorubicin administration.
    Toyoda Y; Okada M; Kashem MA
    J Thorac Cardiovasc Surg; 1998 Jun; 115(6):1367-73. PubMed ID: 9628680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of chronic toxic effects of daunorubicin and doxorubicin in rabbits.
    Klimtová I; Simůnek T; Mazurová Y; Hrdina R; Gersl V; Adamcová M
    Hum Exp Toxicol; 2002 Dec; 21(12):649-57. PubMed ID: 12540035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective left ventricular adriamycin-induced cardiomyopathy in the pig.
    Christiansen S; Perez-Bouza A; Schälte G; Hilgers RD; Autschbach R
    J Heart Lung Transplant; 2008 Jan; 27(1):86-92. PubMed ID: 18187092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A stable model of chronic bilateral ventricular insufficiency (dilated cardiomyopathy) induced by arteriovenous anastomosis and doxorubicin administration in sheep.
    Chekanov VS
    J Thorac Cardiovasc Surg; 1999 Jan; 117(1):198-9. PubMed ID: 9869781
    [No Abstract]   [Full Text] [Related]  

  • 10. Preliminary echocardiographic and polygraphic evaluation of cardiac toxicity of 4'-epi-doxorubicin.
    Villani F; Comazzi R; Lacaita G; Genitoni V; Guindani A; Martini A
    Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):203-8. PubMed ID: 6574995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling Human Myocardium Exposure to Doxorubicin Defines the Risk of Heart Failure from Low-Dose Doxorubicin.
    Salvatorelli E; Menna P; Chello M; Covino E; Minotti G
    J Pharmacol Exp Ther; 2017 Aug; 362(2):263-270. PubMed ID: 28559479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive monitoring of cardiac hemodynamic parameters in doxorubicin-treated patients: comparison with echocardiography.
    Villani F; Meazza R; Materazzo C
    Anticancer Res; 2006; 26(1B):797-801. PubMed ID: 16739356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remodeling of ventricular repolarization in a chronic doxorubicin cardiotoxicity rat model.
    Kharin S; Krandycheva V; Tsvetkova A; Strelkova M; Shmakov D
    Fundam Clin Pharmacol; 2013 Aug; 27(4):364-72. PubMed ID: 22429163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood.
    Lipshultz SE; Colan SD; Gelber RD; Perez-Atayde AR; Sallan SE; Sanders SP
    N Engl J Med; 1991 Mar; 324(12):808-15. PubMed ID: 1997853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The beneficial effect of n-3 polyunsaturated fatty acids on doxorubicin-induced chronic heart failure in rats.
    Teng LL; Shao L; Zhao YT; Yu X; Zhang DF; Zhang H
    J Int Med Res; 2010; 38(3):940-8. PubMed ID: 20819430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late cardiotoxicity after treatment for a malignant bone tumor.
    Postma A; Bink-Boelkens MT; Beaufort-Krol GC; Kengen RA; Elzenga NJ; Schasfoort-van Leeuwen MJ; Schraffordt koops H; Kamps WA
    Med Pediatr Oncol; 1996 Apr; 26(4):230-7. PubMed ID: 8600333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of left ventricular diameter and mass after surgical arteriovenous fistula closure in renal transplant recipients.
    Unger P; Wissing KM; de Pauw L; Neubauer J; van de Borne P
    Transplantation; 2002 Jul; 74(1):73-9. PubMed ID: 12134102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine changes during the evolution of doxorubicin-induced left ventricular dysfunction in adult lymphoma patients.
    Nousiainen T; Vanninen E; Jantunen E; Remes J; Ritanen E; Vuolteenaho O; Hartikainen J
    Clin Sci (Lond); 2001 Dec; 101(6):601-7. PubMed ID: 11724646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metilin Improves Сardiac Function in Rabbits With Chronic Heart Failure].
    Studneva IM; Lakomkin VL; Veselova OM; Prosvirnin AV; Abramov AA; Pavlovich ER; Lubimov RO; Gramovich VV; Vyborov ON; Pisarenko OI; Kapelko VI
    Kardiologiia; 2018 Jul; 58(7):66-74. PubMed ID: 30081811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer.
    Lipshultz SE; Lipsitz SR; Sallan SE; Simbre VC; Shaikh SL; Mone SM; Gelber RD; Colan SD
    J Clin Oncol; 2002 Dec; 20(23):4517-22. PubMed ID: 12454107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.